NAS
BIIB icon

Nykredit A/S’s Biogen BIIB Stock Holding History

Nykredit A/S’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.02M Buy
+41,734
New +$7.98M 0.03% 405

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nykredit A/S's BIIB Position: Q2 2026 in Review

Nykredit A/S opened a new position in Biogen (BIIB) in Q2 2026: 41,734 shares worth $9.02M. The stake represents 0.03% of the portfolio and ranks #405 among its holdings.

836 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Nykredit A/S held 41,734 shares of Biogen worth $9.02M as of Q2 2026.
  • Biogen was a new Nykredit A/S position in Q2 2026.
  • Biogen made up 0.03% of Nykredit A/S's portfolio in Q2 2026, its #405 holding.
  • 836 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.